AI assistant
PALISADE BIO, INC. — Director's Dealing 2024
Feb 13, 2024
35274_dirs_2024-02-13_d3ea0491-e42c-4e80-b725-a758266be5f5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PALISADE BIO, INC. (PALI)
CIK: 0001357459
Period of Report: 2024-02-08
Reporting Person: Diaz Stephanie (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-02-08 | Common Stock, par value $0.01 | M | 6980 | $0.00 | Acquired | 6980 | Direct |
| 2024-02-08 | Common Stock, par value $0.01 | M | 5820 | $0.00 | Acquired | 12800 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-02-08 | Restricted Stock Units | $ | M | 6980 | Disposed | Common Stock (6980) | Direct | |
| 2024-02-08 | Restricted Stock Units | $ | M | 5820 | Disposed | Common Stock (5820) | Direct | |
| 2024-02-08 | Common Stock Options | $1.60 | M | 9580 | Disposed | 2033-06-11 | Common Stock (9580) | Direct |
| 2024-02-08 | Common Stock Options | $1.60 | M | 9580 | Acquired | 2033-06-11 | Common Stock (9580) | Direct |
| 2024-02-08 | Common Stock Options | $0.59 | M | 6880 | Disposed | 2033-11-21 | Common Stock (6880) | Direct |
| 2024-02-08 | Common Stock Options | $0.59 | M | 6880 | Acquired | 2033-11-21 | Common Stock (6880) | Direct |
Footnotes
F1: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units granted on June 11, 2023, resulting from the full accelerated vesting in connection with Reporting Person's resignation from the Issuer's Board of Directors.
F2: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units granted on November 21, 2023, resulting from the full accelerated vesting in connection with Reporting Person's resignation from the Issuer's Board of Directors.
F3: This restricted stock unit was granted on June 11, 2023 and pursuant to the issuance upon full vesting as described in Footnote 1, is no longer outstanding.
F4: This restricted stock unit was granted on November 21, 2023 and pursuant to the issuance upon full vesting described in Footnote 2, is no longer outstanding.
F5: Each restricted stock unit represents the right to receive one share of common stock.
F6: Each option represents the right to purchase one share of common stock at the exercise price.
F7: Represents the modification of the option granted on June 11, 2023, resulting in (i) immediate vesting in full of the outstanding grant and (ii) extension of the exercise period until the expiration date in connection with Reporting Person's resignation from the Issuer's Board of Directors.
F8: Represents the modification of the option granted on November 21, 2023, resulting in (i) immediate vesting in full of the outstanding grant and (ii) extension of the exercise period until the expiration date in connection with Reporting Person's resignation from the Issuer's Board of Directors.